Hyperdynamic circulation as well as increased hepatic larly regarding portal pressure, has not been fully elucidated yet. Therefore, mainly ET-1 will be covered in the resistance contribute to portal hypertension in cirrhosis of the liver [1] . Hyperdynamic circulation with increased following text. cardiac output, heart rate and plasma volume and decreased arterial blood pressure and systemic vasodilatation is pivotal for the hyperdynamic circulation. This
ET Plasma Concentration and Hepatic Release in Cirrhosis
has prompted intense research of a number of endogenous neurohumoral mediators with vasodilating properties (NO, natriuretic peptides, glucagon, etc.) [2, 3] .
In patients with cirrhosis of the liver, elevated arterial and venous plasma concentrations of ET-1 and ET-3 In recent years, however, mechanisms augmenting intrahepatic vascular resistance and thus contributing to have been described [2, [10] [11] [12] [13] [14] [15] [16] . Interestingly, there is an increased hepatosplanchnic release of ET in these patients portal hypertension have received increasing attention. In this respect, endothelins (ET) are of particular interest ( fig. 1) . Release of ET-1 as well as arterial and venous plasma concentrations were found to correlate to the [4] [5] [6] [7] [8] .
ET are a family of 21-amino acid polypeptides with hepatic-venous-pressure gradient [13, 14] . In the liver of cirrhotic rats, increased concentrations of ET-1 and an potent vasoactive properties. ET-1 was first isolated in the supernatant of vascular endothelial cells [8] but later increased ET receptor density have been described [17] .
Furthermore, release of ET from isolated perfused liver synthesis of both circulating isopeptides ET-1 and ET-3 was shown in other organs such as the gastrointestinal as well as from sinusoidal endothelial cells upon stimulation by TGF-have been observed [18, 19] . These findtract [9] . ET-1 has mainly vasoconstrictive properties by acting on the ET A receptor on smooth muscle cells. ings raise the question which cells of the liver synthesize ET and whether this is stimulated in liver damage or ET-1 binds with lower affinity also to the ET B receptor on endothelial cells inducing a vasodilatation by the re-cirrhosis. lease of NO and prostacyclins. ET-1 exhibits a much higher affinity to the ET A receptor than ET-3 whereas the ET B receptor exhibits similar affinity for both isopeptides. [25] [26] [27] . As shown recently, ETand to a lesser extent in Kupffer cells (table 1) ; following induced decrease of the hepatic microvascular blood flow liver injury by bile duct ligation prepro-ET-1 mRNA inis predominantly mediated by the contraction of stellate creased mainly in stellate cells and to a lesser extent in cells [26, [28] [29] [30] . Therefore, an autocrine effect of ET endothelial cells [20] . These data support the finding of appears as an interesting pathomechanism of portal hy-ET-1 overexpression in stellate cells and sinusoidal endopertension: in liver damage, increased ET synthesis from thelial cells of human cirrhotic liver [21] . Hepatic stellate stellate cells may induce an increase of portal pressure by cells are located in the space of Disse and surround the contraction of these cells. Furthermore, recent evidence sinusoidal capillary composed of endothelial cells and suggests an effect of ET on hepatic microvascular exKupffer cells. This anatomic location suggests a role of change in cirrhosis, possibly by affecting the fenestration stellate cells in the regulation of the diameter of liver of sinusoidal endothelial cells [31] . This might be another sinusoids and thus of portal pressure. The data on inmechanism contributing to a decrease of hepatic function creased hepatic synthesis of ET in liver damage raise the in cirrhosis. Finally, the increase of portal pressure upon issue of how ET affects portal pressure and whether there Kupffer cell stimulation seems to be partly mediated by might be endocrine or paracrine effects involved.
ET as was recently shown in isolated perfused rat liver [32] . In summary: In conclusion, plasma concentrations of
ET and Portal Pressure
ET are increased in cirrhosis which may be due to increased hepatosplanchnic release. This could reflect ET causes an increase of portal pressure in vivo as increased hepatic synthesis of ET-1, mainly by stellate well as in isolated perfused liver [22, 23] . In cirrhotic and sinusoidal endothelial cells. ET increases portal presliver, but not in controls, portal pressure decreases upon 
